Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$197.69 - $227.29 $1,976 - $2,272
-10 Reduced 0.61%
1,633 $371,000
Q2 2023

Aug 04, 2023

SELL
$211.93 - $241.33 $5,722 - $6,515
-27 Reduced 1.62%
1,643 $396,000
Q1 2023

Apr 19, 2023

SELL
$213.32 - $257.83 $5,333 - $6,445
-25 Reduced 1.47%
1,670 $383,000
Q2 2022

Aug 02, 2022

SELL
$213.86 - $277.87 $64,158 - $83,361
-300 Reduced 15.04%
1,695 $397,000
Q2 2022

Jul 13, 2022

BUY
$213.86 - $277.87 $64,158 - $83,361
300 Added 17.7%
1,995 $550,000
Q4 2021

Jan 21, 2022

SELL
$271.6 - $314.21 $81,480 - $94,263
-300 Reduced 15.04%
1,695 $533,000
Q2 2021

Jul 16, 2021

SELL
$251.87 - $278.14 $28,965 - $31,986
-115 Reduced 5.45%
1,995 $550,000
Q1 2021

Apr 12, 2021

BUY
$204.88 - $255.03 $121,903 - $151,742
595 Added 39.27%
2,110 $538,000
Q4 2020

Feb 08, 2021

SELL
$186.91 - $214.42 $10,840 - $12,436
-58 Reduced 3.69%
1,515 $308,000
Q3 2020

Oct 13, 2020

BUY
$167.03 - $201.3 $20,544 - $24,759
123 Added 8.48%
1,573 $296,000
Q2 2020

Jul 09, 2020

BUY
$113.31 - $182.44 $164,299 - $264,538
1,450 New
1,450 $241,000
Q1 2020

May 08, 2020

SELL
$104.32 - $195.28 $140,832 - $263,628
-1,350 Closed
0 $0
Q2 2019

Jul 24, 2019

SELL
$144.16 - $172.9 $10,812 - $12,967
-75 Reduced 5.26%
1,350 $233,000
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $176,272 - $222,727
1,425 New
1,425 $218,000
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $172,168 - $248,078
-1,425 Closed
0 $0
Q3 2018

Nov 27, 2018

SELL
$167.67 - $188.27 $16,767 - $18,827
-100 Reduced 6.56%
1,425 $234,000
Q2 2018

Aug 16, 2018

SELL
$160.33 - $189.41 $60,123 - $71,028
-375 Reduced 19.74%
1,525 $275,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,900
1,900 $304,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.